BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/12/2024 3:43:32 AM | Browse: 122 | Download: 523
 |
Received |
|
2024-07-20 03:34 |
|
Peer-Review Started |
|
2024-07-20 03:34 |
|
First Decision by Editorial Office Director |
|
2024-08-17 04:39 |
|
Return for Revision |
|
2024-08-17 04:39 |
|
Revised |
|
2024-08-27 15:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-09-19 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-19 07:47 |
|
Articles in Press |
|
2024-09-19 07:47 |
|
Edit the Manuscript by Language Editor |
|
2024-09-23 05:07 |
|
Typeset the Manuscript |
|
2024-09-26 07:09 |
|
Publish the Manuscript Online |
|
2024-10-12 03:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Novel intervention for alcohol-associated liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Fei-Qiong Gao, Jia-Qi Zhu and Xu-Dong Feng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xu-Dong Feng, MD, PhD, Doctor, Doctor, Department of Clinical Laboratory, Ningbo Medical Center Lihuili Hospital, The Affiliated Lihuili Hospital of Ningbo University, No. 57 Xingning Road, Ningbo 315000, Zhejiang Province, China. xdfeng@zju.edu.cn |
| Key Words |
Pathogenesis; Therapy; Peroxisome proliferator activated receptor α/δ; Elafibranor; Alcohol-associated liver disease |
| Core Tip |
Alcohol-associated liver disease (ALD) remains a significant global health challenge. The peroxisome proliferator-activated receptors α and δ (PPARα/δ) play a crucial role in the pathogenesis of ALD. Elafibranor, a dual PPARα/δ activator, shows promise as a potential therapeutic agent for ALD. |
| Publish Date |
2024-10-12 03:43 |
| Citation |
Gao FQ, Zhu JQ, Feng XD. Novel intervention for alcohol-associated liver disease. World J Gastroenterol 2024; 30(39): 4308-4312 |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i39/4308.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i39.4308 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
